We are live on ! Find out more
OCM

Osterweis Capital Management Portfolio holdings

AUM $2.12B
1-Year Est. Return 32.36%
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+32.36%
3 Year Est. Return
+93.72%
5 Year Est. Return
+113.14%
10 Year Est. Return
+557.09%
AUM
$1.51B
AUM Growth
+$40.5M
Cap. Flow
-$150M
Cap. Flow %
-9.95%
Top 10 Hldgs %
29.83%
Holding
220
New
15
Increased
57
Reduced
40
Closed
11

Top Buys

Rank Stock Value
1
A icon
Agilent Technologies
A
+$21.5M
2
TGT icon
Target
TGT
+$9.89M
3
LHX icon
L3Harris
LHX
+$8.69M
4
DG icon
Dollar General
DG
+$6.78M
5
MU icon
Micron Technology
MU
+$5.89M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$25.7M
2
CVS icon
CVS Health
CVS
+$19.8M
3
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$5.08M
4
PLNT icon
Planet Fitness
PLNT
+$4.77M
5
LNTH icon
Lantheus
LNTH
+$4.47M

Sector Composition

Rank Sector Weight
1 Technology 23.48%
2 Healthcare 16.46%
3 Industrials 13.26%
4 Miscellaneous 10.92%
5 Consumer Staples 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GNRC icon
76
Generac Holdings
GNRC
$10.3B
$2.66M 0.18%
+17,860
New +$2.04M
BRK.A icon
77
Berkshire Hathaway Class A
BRK.A
$1.1T
$2.59M 0.17%
5
-2
-29% -$996K
BOOT icon
78
Boot Barn
BOOT
$3.89B
$2.06M 0.14%
24,340
-19,995
-45% -$1.47M
PRCT icon
79
Procept Biorobotics
PRCT
$1.11B
$2.01M 0.13%
56,970
-28,050
-33% -$927K
IBM icon
80
IBM
IBM
$234B
$1.8M 0.12%
13,450
-3,525
-21% -$455K
BRK.B icon
81
Berkshire Hathaway Class B
BRK.B
$1.11T
$1.28M 0.08%
3,746
-3,156
-46% -$1.03M
XOM icon
82
ExxonMobil
XOM
$696B
$1.16M 0.08%
10,842
– –
CATX icon
83
Perspective Therapeutics
CATX
$312M
$1.06M 0.07%
158,210
– –
HD icon
84
Home Depot
HD
$305B
$1.01M 0.07%
3,260
+313
+11% +$92.5K
MDGL icon
85
Madrigal Pharmaceuticals
MDGL
$12.1B
$991K 0.07%
+4,288
New +$1.16M
ESS icon
86
Essex Property Trust
ESS
$17.7B
$950K 0.06%
4,055
– –
AKYA
87
DELISTED
Akoya BioSciences
AKYA
$932K 0.06%
126,131
– –
PLTR icon
88
Palantir
PLTR
$415B
$839K 0.06%
54,761
– –
NVDA icon
89
NVIDIA
NVDA
$5.12T
$710K 0.05%
16,790
+2,800
+20% +$93K
CRM icon
90
Salesforce
CRM
$210B
$694K 0.05%
3,283
+2,700
+463% +$551K
ABBV icon
91
AbbVie
ABBV
$465B
$672K 0.04%
4,991
-130
-3% -$19.1K
MRK icon
92
Merck
MRK
$355B
$652K 0.04%
5,647
-85
-1% -$9.65K
XLK icon
93
State Street Technology Select Sector SPDR ETF
XLK
$119B
– –
0
– –
WFC icon
94
Wells Fargo
WFC
$271B
$593K 0.04%
13,896
– –
GOOGL icon
95
Alphabet (Google) Class A
GOOGL
$4.22T
$564K 0.04%
4,715
+715
+18% +$82.3K
VOO icon
96
Vanguard S&P 500 ETF
VOO
$1.04T
– –
0
– –
TMO icon
97
Thermo Fisher Scientific
TMO
$237B
$522K 0.03%
1,000
-47
-4% -$25.4K
ISTB icon
98
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.09B
– –
0
– –
HYS icon
99
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.79B
– –
0
– –
ABT icon
100
Abbott
ABT
$177B
$460K 0.03%
4,215
– –
2 3
4
5 6

Similar funds

SP
Stairway Partners Chicago, Illinois $2.12B AUM 17.37% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return
MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
PCM
Philosophy Capital Management Alamo, California $2.12B AUM 39.96% 1-Year Est. Return
MWA
Midland Wealth Advisors Effingham, Illinois $2.13B AUM 17.72% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $2.13B AUM 6.1% 1-Year Est. Return
PSC
Portman Square Capital London, United Kingdom $2.11B AUM 19.71% 1-Year Est. Return

Osterweis Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Osterweis Capital Management held 220 positions worth $1.51B, up 2.8% from $1.47B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Osterweis Capital Management withdrew a net $150M in Q2 2023, closing 11 positions and reducing 40 holdings. Its most notable exit was CVS Health, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Osterweis Capital Management opened a new position in The Ensign Group worth $3.95M.

  • Osterweis Capital Management's largest Q2 2023 buy was The Ensign Group: 41,370 shares worth $3.95M.
  • Osterweis Capital Management added most to Agilent Technologies in Q2 2023, an estimated $21.5M increase.
  • Osterweis Capital Management's biggest Q2 2023 reduction was Oracle, cutting an estimated $25.7M.
  • Osterweis Capital Management fully exited CVS Health in Q2 2023, selling an estimated $19.8M.
  • Osterweis Capital Management's ten largest holdings make up 30% of its $1.51B portfolio in Q2 2023.
  • Osterweis Capital Management opened 15 new positions and closed 11 in Q2 2023.
  • Osterweis Capital Management's portfolio value rose 2.8% quarter-over-quarter to $1.51B.

Based on Osterweis Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.